200,000+ products from a single source!
sales@angenechem.com
24967-27-9 | D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-2,6-anhydro-3,5-dideoxy-
CAS No: 24967-27-9 Catalog No: AG002Q0N MDL No:MFCD00057470
Product Description
Catalog Number:
AG002Q0N
Chemical Name:
D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-2,6-anhydro-3,5-dideoxy-
CAS Number:
24967-27-9
Molecular Formula:
C11H17NO8
Molecular Weight:
291.2546
MDL Number:
MFCD00057470
IUPAC Name:
(2R,3R,4S)-3-acetamido-4-hydroxy-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
InChI:
InChI=1S/C11H17NO8/c1-4(14)12-8-5(15)2-7(11(18)19)20-10(8)9(17)6(16)3-13/h2,5-6,8-10,13,15-17H,3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,8+,9+,10+/m0/s1
InChI Key:
JINJZWSZQKHCIP-UFGQHTETSA-N
SMILES:
OC[C@H]([C@H]([C@@H]1OC(=C[C@@H]([C@H]1NC(=O)C)O)C(=O)O)O)O
EC Number:
246-550-7
Properties
Complexity:
409
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
5
Defined Bond Stereocenter Count:
0
Exact Mass:
291.095g/mol
Formal Charge:
0
Heavy Atom Count:
20
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
6
Isotope Atom Count:
0
Molecular Weight:
291.256g/mol
Monoisotopic Mass:
291.095g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
157A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.5
Literature
| Title | Journal |
|---|---|
| Exploring the interactions of unsaturated glucuronides with influenza virus sialidase. | Journal of medicinal chemistry 20121025 |
| Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity. | Bioorganic & medicinal chemistry 20120715 |
| Molecular modeling of T. rangeli, T. brucei gambiense, and T. evansi sialidases in complex with the DANA inhibitor. | Chemical biology & drug design 20120701 |
| NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not. | The Journal of biological chemistry 20120504 |
| Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. | Glycobiology 20120201 |
| Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes. | Bioorganic & medicinal chemistry 20110501 |
| Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1. | Bioorganic & medicinal chemistry 20110401 |
| A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death. | Journal of biochemistry 20110201 |
| Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses. | PloS one 20110101 |
| Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid. | Bioorganic & medicinal chemistry letters 20101215 |
| Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles. | Journal of medicinal chemistry 20101028 |
| Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. | Bioorganic & medicinal chemistry 20100601 |
| Complexity in influenza virus targeted drug design: interaction with human sialidases. | Journal of medicinal chemistry 20100408 |
| 'Click chemistry' synthesis of a library of 1,2,3-triazole-substituted galactose derivatives and their evaluation against Trypanosoma cruzi and its cell surface trans-sialidase. | Bioorganic & medicinal chemistry 20100401 |
| The effect of neuraminidase blocker on gabazine-induced seizures in rat hippocampus. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20100101 |
| Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids. | Bioorganic & medicinal chemistry 20090701 |
| Efficient method for the preparation of peracetylated Neu5Ac2en by flash vacuum pyrolysis. | The Journal of organic chemistry 20090605 |
| Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. | The Journal of infectious diseases 20090515 |
| Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening. | Bioorganic & medicinal chemistry letters 20090201 |
| Crystal structure of the NanB sialidase from Streptococcus pneumoniae. | Journal of molecular biology 20081212 |
| Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. | Antimicrobial agents and chemotherapy 20081001 |
| Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA. | Acta crystallographica. Section F, Structural biology and crystallization communications 20080901 |
| 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1. | Bioorganic & medicinal chemistry 20080715 |
| Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells. | Biochimica et biophysica acta 20080501 |
| Investigation into an efficient synthesis of 2,3-dehydro-N-acetyl neuraminic acid leads to three decarboxylated sialic acid dimers. | Carbohydrate research 20080407 |
| Photoaffinity labeling of sialidase with a biotin-conjugated phenylaminodiazirine derivative of 2,3-didehydro-2-deoxy-N-acetylneuraminic acid. | Biological & pharmaceutical bulletin 20080301 |
| Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1). | Bioorganic & medicinal chemistry letters 20080115 |
| Sialidase activity in Mycoplasma synoviae. | Avian diseases 20071201 |
| Role of sialidase in Mycoplasma alligatoris-induced pulmonary fibroblast apoptosis. | Veterinary microbiology 20070331 |
| Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity. | Bioorganic & medicinal chemistry letters 20070315 |
| STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core. | Glycobiology 20070101 |
| 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1. | Bioorganic & medicinal chemistry 20061201 |
| Preparation of a fluorous protecting group and its application to the chemoenzymatic synthesis of sialidase inhibitor. | Chemical communications (Cambridge, England) 20060807 |
| Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. | Biochemical and biophysical research communications 20060609 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| A QSAR study on influenza neuraminidase inhibitors. | Bioorganic & medicinal chemistry 20060215 |
| Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus. | Glycoconjugate journal 20060201 |
| A sialidase mutant displaying trans-sialidase activity. | Journal of molecular biology 20050128 |
| Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition. | The Journal of biological chemistry 20050107 |
| Reduction in the adherence of Pseudomonas aeruginosa to human buccal epithelial cells with neuraminidase inhibition. | Polish journal of microbiology 20050101 |
| Structural analogs of sialic acid interfere with the binding of erythrocyte binding antigen-175 to glycophorin A, an interaction crucial for erythrocyte invasion by Plasmodium falciparum. | Molecular and biochemical parasitology 20041101 |
| Sialic acid recognition by Vibrio cholerae neuraminidase. | The Journal of biological chemistry 20040924 |
| Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase. | Proteins 20040801 |
| Localization of sialidase-positive cells expressing Mac-1 and immunoglobulin in the mouse thymus. | Glycoconjugate journal 20040101 |
| Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations. | Journal of medicinal chemistry 20031218 |
| Inhibition of influenza A virus sialidase activity by sulfatide. | FEBS letters 20031023 |
| Oxochromium(V) species formed with 2,3-dehydro-2-deoxy-N-acetylneuraminic or N-acetylneuraminic (sialic) acids: an in vitro model system of oxochromium(V) species potentially stabilized in the respiratory tract upon inhalation of carcinogenic chromium(VI) compounds. | Chemical research in toxicology 20030701 |
| The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase. | Journal of molecular biology 20030124 |
| Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives. | Bioorganic & medicinal chemistry letters 20020805 |
| Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives. | Bioorganic & medicinal chemistry letters 20020805 |
| Computational 3-D modeling and site-directed mutation of an antibody that binds Neu2en5Ac, a transition state analogue of a sialic acid. | Proteins 20011201 |
| Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains. | FEBS letters 20010420 |
| Analysis of inhibitor binding in influenza virus neuraminidase. | Protein science : a publication of the Protein Society 20010401 |
| Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid. | Glycoconjugate journal 20010401 |
| Synthesis of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified at the C-4 and C-9 positions and their behaviour towards sialidase from influenza virus and pig liver membrane. | Carbohydrate research 20010115 |
| BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. | Journal of medicinal chemistry 20000921 |
| A novel approach to antiviral therapy for influenza. | The Journal of antimicrobial chemotherapy 19991101 |
| Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. | Journal of medicinal chemistry 19990701 |
| Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. | Journal of medicinal chemistry 19980312 |
| Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. | Journal of medicinal chemistry 19971205 |
| A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. | Journal of medicinal chemistry 19960119 |
| Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. | Journal of medicinal chemistry 19950818 |
| Structures of aromatic inhibitors of influenza virus neuraminidase. | Biochemistry 19950314 |
| 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. | Antimicrobial agents and chemotherapy 19930701 |
| Rational design of potent sialidase-based inhibitors of influenza virus replication. | Nature 19930603 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.